News Digest / Lukas Schmidt

Author: Lukas Schmidt

09:39am, Wednesday, Dec 10, 2025
HeartBeam Inc (NASDAQ:BEAT) shares surged following FDA clearance for its innovative 12-lead ECG synthesis software, enabling cardiac patients to monitor arrhythmias remotely with clinical-grade precision.